RIPK1-targeted therapy alleviates intervertebral disc degeneration via inhibiting nucleus pulposus PANoptosis. - Zhu Z; Kong F; Jiang F; Jiang J; Quan D; Guo J; Sun K; Shi J; Wang C; Zhuang C; Xu X (Apoptosis : an international journal on programmed cell death, 2025)